National Taiwan University Hospital (NTUH) has consulted with the United States and is to start clinical trials in Taiwan of the antiviral drug remdesivir for the treatment of COVID-19 coronavirus, the Central Epidemic Command Center (CECC) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open higher
10/09/2025 09:13 AM - Society
Taiwan headline news
10/09/2025 08:54 AM - Science & Tech
Tang Prize laureate Omar M. Yaghi wins Nobel Prize in Chemistry
10/08/2025 10:05 PM - Science & Tech
Nobel laureate John Martinis hails Taiwan's scientific potential
10/08/2025 09:27 PM - Business
Taiwan's September CPI growth slows to 1.25%, lowest in 4.5 years: DGBAS
10/08/2025 08:53 PM